| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |